Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses Zika virus diagnostics.
Interview Transcript (slightly modified for readability)
“There have been several advances in terms of diagnostic techniques for Zika. Now, the [Centers for Disease Control and Prevention (CDC)] recommends that commercial labs be used for a majority of patients. That’s going to affect the turnaround time in terms of diagnostics, so, that’s going to help dramatically. That might change the way that hospitals address their surveillance component for Zika.
It’ll allow a quicker turnaround time for identifying patients, and also for ruling out certain patients who may have been exposed to Zika but have no evidence of infection. That can change the way that [hospitals] allocate certain resources like ultrasounds and further blood testing.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512